2.Correlation of homocysteine with diabetic microangiopathy and the change after drug intervention.
Fang XIE ; Dong LV ; Wei-Bin CHEN ; Yan-Zu LIN
Journal of Southern Medical University 2016;36(11):1573-1576
OBJECTIVETo explore the correlation of homocysteine with diabetic microangiopathy and the change after drug intervention.
METHODSA total of 200 patients with type 2 diabetes were selected between January and December 2013. The patients were divide into group of no microvascular disease and group of microvascular lesion according to the complications. Blood lipid, blood glucose, renal function and serum homocysteine were deteced pre-treatment and after 6 months treatment.A total of 100 cases of healthy subjects with physical examination over the same period were selected as control group according to the principle of age and gender matching.
RESULTSSBP, DBP, TG, TC, LDL, FBG, 2 hPBG, HbA1, SUN, SCr and HCY in group of no microvascular disease and group of microvascular lesion were significantly higher than that in control group(P<0.01), while HDL were significantly lower(P<0.01); SBPDBP,SUN,SCr and HCY in group of microvascular lesion were significantly higher than that in group of no microvascular disease(P<0.01); Multi factor Logistic regression analysis showed blood pressure, urea nitrogen, serum creatinine and homocysteine levels are risk factors for microvascular complications in patients with diabetes mellitus; HCY after treatment were significantly lower than that before treatment in group of no microvascular disease and group of microvascular lesion than(P<0.01).
CONCLUSIONHigh homocysteine levels are risk factor of diabetic microvascular disease, and the homocysteine levels can be reduced after treatment.
3.In vitro evaluation of cutaneous allergic reaction induced by chemicals using dendritic cells.
Yu-bin ZHANG ; Hui-fen LIN ; Luo LV ; Wei-guang HUA ; Fang TIAN ; Guang-zu SHEN ; Zhao-lin XIA ; Xi-peng JIN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2008;26(3):147-150
OBJECTIVETo investigate the use of dendritic cells derived from mice bone marrow to evaluate the cutaneous allergic reaction induced by chemical sensitizers.
METHODSDendritic cells derived from mice bone marrow were cultured and administrated with 2, 4-dinitrochlorobenzene (DNCB), nickel sulfate (NiSO4), sodium dodecyl sulfate (SDS) and hexyl cinnamic aldehyde (HCA), respectively. Cell membrane molecule CD86 and extracellular IL-1 beta, IL-6 and IL-12 were detected after 0, 1, 6, 12, 24, 36, 48 hour's administration, respectively.
RESULTSCD86 expression reached the highest level after exposure to DNCB for 48 h, and increased by about 279% compared with the control (P < 0.05), while it was lower than that of control after administrated with NiSO4 and HCA for 1 h and 6 h, and SDS for 36 h, respectively (P < 0.05). Extracellular IL-1 beta increased greatly after exposure to NiSO4 just for 1 h, with the maximum at 48 h (298 pg/ml, P < 0.05), and after exposure to HCA for 6 h, with maximum at 48 h (84 pg/ml, P < 0.05). However, it didn't fluctuate significantly after administrated with DNCB and SDS respectively, compared with the control. Extracellular IL-6 increased significantly after exposure to NiSO4 for 1 h, with the maximum at 24 h (2152 pg/ml, P < 0.05). After exposure to HCA, extracellular IL-6 reached the maximum at 1 h (1403 pg/ml), and then it was decreased quickly, but still higher than the control (P < 0.05), while it didn't change significantly after treatment with DNCB and SDS, compared with the control (P > 0.05). Extracellular IL-12 was not detected out among all the groups.
CONCLUSIONChemical sensitizer DNCB could induce the high expression of CD86 on DC membrane, and NiSO4 and HCA could induce DC to release IL-1 beta and IL-6. However, the irritant SDS had no such effect.
Animals ; B7-2 Antigen ; metabolism ; Cells, Cultured ; Dendritic Cells ; drug effects ; immunology ; metabolism ; Dinitrochlorobenzene ; pharmacology ; Interleukin-12 ; metabolism ; Interleukin-1beta ; metabolism ; Interleukin-6 ; metabolism ; Mice ; Mice, Inbred C57BL ; Nickel ; pharmacology ; Sodium Dodecyl Sulfate ; pharmacology